You should read the financial statement properly. The opertaing business is almost $300K EBITDA positive each quarter. The R&D cash is on top off that. Even without the R&D the change from the $600k loss in Q2FY23 to $300K profit in Q2FY24 is almost a $1M turnaround and has made the business sustainable. The additional cash advance under the R&D scheme has also helped clear $1M in debt from the balance sheet in the past 12 months.
Disengenous would be hiding the R&D in the revenue line. It isnt. That you could see it says its nothing more or less than a fact.
- Forums
- ASX - By Stock
- Ann: NNG Quarterly Activities Report and Appendix 4C Dec-23
You should read the financial statement properly. The opertaing...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NNG (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.046M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NNG (ASX) Chart |
Day chart unavailable